Comparative Antimicrobial Characterization of LBM415 (NVP PDF-713), a New Peptide Deformylase Inhibitor of Clinical Importance

LBM415 (NVP PDF-713) is the first member of the peptide deformylase (PDF) inhibitor class being developed for clinical trials as a parenteral and oral agent for treatment of community-acquired respiratory tract disease and serious infections caused by antimicrobial-resistant gram-positive cocci. In...

Full description

Saved in:
Bibliographic Details
Main Authors: Fritsche, Thomas R., Sader, Helio S., Cleeland, Roy, Jones, Ronald N.
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 2005
Subjects:
Susceptibility
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1068652/
https://ncbi.nlm.nih.gov/pubmed/15793128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.4.1468-1476.2005
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items